Articles related to Rheumatology

Taken from the Annals of Internal Medicine, these clinical guidelines describe best practices for prescribing appropriate and short-duration antibiotic therapy for patients presenting with these four infections: acute bronchitis with chronic obstructive pulmonary disease (COPD) exacerbation, community-acquired pneumonia (CAP), urinary tract infections (UTIs), and cellulitis.

US News & World Report recently published its state healthcare rankings, based on three measures: access to healthcare, quality of care, and overall health of the population, measuring rates of obesity, smoking, suicide, mental health, and mortality for adults and infants. At the top, Hawaii was the clear winner. At the bottom, Mississippi. Where does your state measure up in the rankings?

The IRS was kind enough to move the traditional tax deadline from April 15 to Monday, May 17, granting a bit of a reprieve for getting your financial affairs in order. Many physicians choose to handle their taxes themselves despite a good CPA paying for him/herself in the deductions and tax-savings strategies that they find for you. If you decide to go this route, here are some things you should be asking.

The FDA announced a trial hold after two participants with sickle cell disease (SCD) in the LentiGlobin gene therapy trials developed AML and MDS. According to bluebird bio, the manufacturer of LentiGlobin products, the company was unable to find any cancer cells in the patient’s bone marrow and has asked the FDA for permission to resume clinical trials.

According to a recent study published in Clinical Toxicology, the authors examined the makeup of 17 brands of OTC supplements in the US, purchased online, that were labeled to include banned and unapproved stimulants, including deterenol, a beta-agonist that has never been approved for use in the US and which the FDA banned from supplements in 2004.

This article from Radiopaedia discusses inclusions, usage, assessment of treatment response, caveats, history, and etymology of the internationally recognized Deauville five-point scale (Deauville 5PS), which was proposed in an international workshop attended by hematologists and nuclear medicine specialists in Deauville, France in 2009.